Publications by authors named "Christopher Viereck"

Claim this Profile
E
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Dominique P Germain, Kathy Nicholls, Roberto Giugliani, Daniel G Bichet, Derralynn A Hughes, Christopher Viereck

Genet Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, Gere Sunder-Plassmann, David Koeller, Christopher Viereck

J Med Genet· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, Daniel G Bichet, Roberto Giugliani, Christopher Viereck

N Engl J Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development.
Christopher Viereck, Pol Boudes

Contemp Clin Trials· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible.
Christopher Viereck, Pol Boudes

Contemp Clin Trials· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis